Sinclair Pharma PLC Additional Listing (4681P)
November 17 2016 - 5:36AM
UK Regulatory
TIDMSPH
RNS Number : 4681P
Sinclair Pharma PLC
17 November 2016
Sinclair Pharma plc
Additional listing
London, 17 November 2016 Sinclair Pharma plc (SPH.L),
("Sinclair" or the "Company") the international aesthetics company,
announces that 108,934 new ordinary shares of 1p each (the "New
Ordinary Shares") have been issued and allotted pursuant to the
vesting of awards and exercise of share options under the Company's
2003 Executive Incentive Plan. 6,748 of these New Ordinary Shares
have been issued to Alan Olby, Chief Financial Officer, following
the exercise of Replacement Options under the Company's 2003
Executive Incentive Plan.
Application has been made to the London Stock Exchange for the
New Ordinary Shares to be admitted to trading on AIM. Admission is
expected to be effective on 22 November 2016 and, when issued, the
New Ordinary Shares will rank pari passu in all respects with the
Company's existing ordinary shares.
Following admission of the New Ordinary Shares, Sinclair will
have 502,198,442 ordinary shares of 1p in issue.
This announcement contains inside information.
For further information please contact:
Sinclair Pharma Tel: +44 (0)
plc 20 7467 6920
Chris Spooner
Alan Olby
Andy Crane
Peel Hunt LLP (NOMAD Tel: +44 (0)
and Broker) 20 7418 8900
James Steel
Oliver Jackson
Media enquiries
FTI Consulting Tel: +44 (0)
203 727 1000
Ben Atwell
Brett Pollard
Notes to Editors:
About Sinclair Pharma plc
Sinclair Pharma plc is an international company operating in the
fast growth, high gross margin, global aesthetics market. Sinclair
has built a strong portfolio of differentiated, complementary
aesthetics technologies, which are experiencing significant growth,
targeting unmet clinical needs for effective, high quality, longer
duration, natural looking and minimally-invasive treatments. The
Company is planning entry to multiple new geographic markets and
line extension launches over the next few years. Sinclair has an
established sales and marketing presence in the leading EU markets
and Brazil, and a network of international distributors. For more
information, please visit www.sinclairpharma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
ALSFMMMMGNKGVZM
(END) Dow Jones Newswires
November 17, 2016 05:36 ET (10:36 GMT)
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From Apr 2024 to May 2024
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From May 2023 to May 2024